Reason for request
Inscription
Mise à disposition d'un générique d'Evoltra.
Clinical Benefit
| Substantial |
le service médical rendu par CLOFARABINE TILLOMED 1 mg/ml est important dans l’indication de l’AMM. |
Clinical Added Value
| no clinical added value |
Cette spécialité n’apporte pas d’amélioration du service médical rendu (ASMR V) par rapport à la spécialité princeps EVOLTRA 1 mg/ml, déjà inscrite. |
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
GWkTrbfReN1TSsTM
Listen
